Hexastat en es it fr

Hexastat Brand names, Hexastat Analogs

Hexastat Brand Names Mixture

  • No information avaliable

Hexastat Chemical_Formula

C9H18N6

Hexastat RX_link

http://www.rxlist.com/cgi/generic/altretamine.htm

Hexastat fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=104

Hexastat msds (material safety sheet)

Hexastat Synthesis Reference

No information avaliable

Hexastat Molecular Weight

210.28 g/mol

Hexastat Melting Point

172-174 oC

Hexastat H2O Solubility

91 mg/L

Hexastat State

Solid

Hexastat LogP

1.566

Hexastat Dosage Forms

Capsule

Hexastat Indication

For use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination.

Hexastat Pharmacology

Altretamine is a novel antineoplastic agent. The precise mechanism by which altretamine exerts its cytotoxic effect is unknown, although a number of theoretical possibilities have been studied. Structurally, altretamine resembles the alkylating agent triethylenemelamine, yet in vitro tests for alkylating activity of altretamine and its metabolitics have been negative. Altretamine has been demonstrated to be efficacious for certain ovarian tumors resistant to classical alkylating agents. Metabolism of altretamine is a requirement of cytotoxicity. Synthetic monohydroxymethylmelamines, and products of altretamine metabolism, in vitro and in vivo, can form covalent adducts with tissue macromolecules including DNA, but the relevance of these reactions to antitumor activity is unknown.

Hexastat Absorption

No information avaliable

Hexastat side effects and Toxicity

No information avaliable

Hexastat Patient Information

No information avaliable

Hexastat Organisms Affected

Humans and other mammals